Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 3, 2004, Pages 1273-1281

  Ohtsuki, Sumio ^a,b   Kikkawa, Tazuru ^a   Mori, Shinobu ^a   Hori, Satoko ^a,b   Takanaga, Hitomi ^a,b   Otagiri, Masaki ^c   Terasaki, Tetsuya ^a,b  

^a TOHOKU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; BROMSULFOPHTHALEIN; CALCITONIN; CIMETIDINE; DIGOXIN; ESTRADIOL; ESTRADIOL 17 GLUCURONIDE; ESTRONE SULFATE; ETIDRONIC ACID; GLUTARIC ACID; HOMOVANILLIC ACID; INDICAN; INDOMETACIN; LIOTHYRONINE; METHOTREXATE; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 3; PARATHYROID HORMONE; PENICILLIN G; PRAVASTATIN; PROBENECID; PROSTAGLANDIN E2; REDUCED IN OSTEOSCLEROSIS TRANSPORTER; SALICYLIC ACID; TAUROCHOLIC ACID; THYROXINE; TRITIUM; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BONE TURNOVER; BRAIN CAPILLARY; CHOROID PLEXUS; CONTROLLED STUDY; DRUG UPTAKE; ENDOTHELIUM CELL; EYE; GENE EXPRESSION SYSTEM; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; XENOPUS LAEVIS;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CAPILLARIES; DISEASE MODELS, ANIMAL; ESTRONE; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; ORGANIC ANION TRANSPORTERS; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; OSTEOSCLEROSIS; PENICILLIN G; RNA, MESSENGER;

EID: 2442720194     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.063370     Document Type: Article

References (30)

1. Adams JE (2002) Dialysis bone disease. Semin Dial 15:277-289.
2. Ba J, Brown D, and Friedman PA (2003) Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. Am J Physiol 285: F1233-F1243.
3. Brady KP, Dushkin H, Fornzler D, Koike T, Magner F, Her H, Gullans S, Segre GV, Green RM, and Beier DR (1999) A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse. Genomics 56:254-261.
4. Cha SH, Sekine T, Fukushima JI, Kanai Y, Kobayashi Y, Goya T, and Endou H (2001) Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 59:1277-1286.
5. Cha SH, Sekine T, Kusuhara H, Yu E, Kim JY, Kim DK, Sugiyama Y, Kanai Y, and Endou H (2000) Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 275:4507-4512.
6. Deguchi T, Ohtsuki S, Otagiri M, Takanaga H, Asaba H, Mori S, and Terasaki T (2002) Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Kidney Int 61:1760-1768.
7. Enomoto A, Takeda M, Taki K, Takayama F, Noshiro R, Niwa T, and Endou H (2003) Interactions of human organic anion as well as cation transporters with indoxyl sulfate. Eur J Pharmacol 466:13-20.
8. Goldin AL (1992) Maintenance of Xenopus laevis and oocyte injection. Methods Enzymol 207:226-279.
9. Hasegawa M, Kusuhara H, Endou H, and Sugiyama Y (2003) Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. J Pharmacol Exp Ther 305:1087-1097.
10. Hasegawa M, Kusuhara H, Sugiyama D, Ito K, Ueda S, Endou H, and Sugiyama Y (2002) Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions. J Pharmacol Exp Ther 300:746-753.
11. Heaney C, Shalev H, EIbedour K, Carmi R, Staack JB, Sheffield VC, and Beier DR (1998) Human autosomal recessive osteopetrosis maps to 11q13, a position predicted by comparative mapping of the murine osteosclerosis (oc) mutation. Hum Mol Genet 7:1407-1410.
12. Hosoya K, Tetsuka K, Nagase K, Tomi M, Saeki S, Ohtsuki S, Takanaga H, Yanai N, Obinata M, Kikuchi A, et al. (2000) Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene. AAPS Pharm Sci 2:E27.
13. Hudson TJ, Church DM, Greenaway S, Nguyen H, Cook A, Steen RG, Van Etten WJ, Castle AB, Strivens MA, Trickett P, et al. (2001) A radiation hybrid map of mouse genes. Nat Genet 29:201-205.
14. Jutabha P, Kanai Y, Hosoyamada M, Chairoungdua A, Kim do K, Iribe Y, Babu E, Kim JY, Anzai N, Chatsudthipong V, et al. (2003) Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule. J Biol Chem 278:27930-27938.
15. Kajiya H, Okamoto F, Fukushima H, and Okabe K (2003) Calcitonin inhibits proton extrusion in resorbing rat osteoclasts via protein kinase A. Pflueg Arch 445:651-658.
16. Katagiri T and Takahashi N (2002) Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8:147-159.
17. Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, and Endou H (1999) Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 274:13675-13680.
18. + channel determined by construction of multimeric cDNAs. Neuron 9:861-871.
19. Mori S, Takanaga H, Ohtsuki S, Deguchi T, Kang YS, Hosoya K, and Terasaki T (2003) Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J Cereb Blood Flow Metab 23:432-440.
20. Nagata Y, Kusuhara H, Endou H, and Sugiyama Y (2002) Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. Mol Pharmacol 61:982-988.
21. Ohtsuki S, Asaba H, Takanaga H, Deguchi T, Hosoya K, Otagiri M, and Terasaki T (2002) Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem 83:57-66.
22. Scimeca JC, Franchi A, Trojani C, Parrinello H, Grosgeorge J, Robert C, Jaillon O, Poirier C, Gaudray P, and Carle GF (2000) The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 26:207-213.
23. Simard M, Arcuino G, Takano T, Liu QS, and Nedergaard M (2003) Signaling at the gliovascular interface. J Neurosci 23:9254-9262.
24. Sobacchi C, Frattini A, Orchard P, Porras O, Tezcan I, Andolina M, Babul-Hirji R, Baric I, Canham N, Chitayat D, et al. (2001) The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum Mol Genet 10:1767-1773.
25. Stewart PA, Beliveau R, and Rogers KA (1996) Cellular localization of P-glycoprotein in brain versus gonadal capillaries. J Histochem Cytochem 44:679-685.
26. Sugiyama D, Kusuhara H, Shitara Y, Abe T, Meier PJ, Sekine T, Endou H, Suzuki H, and Sugiyama Y (2001) Characterization of the efflux transport of 17β-estradiol-D-17β-glucuronide from the brain across the blood-brain barrier. J Pharmacol Exp Ther 298:316-322.
27. + gradient. Am J Physiol 284:F763-F769.
28. Sweet DH, Miller DS, Pritchard JB, Fujiwara Y, Beier DR, and Nigam SK (2002) Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J Biol Chem 277:26934-26943.
29. Takayanagi R, Goto K, Suzuki S, Tanaka S, Shimoda S, and Nawata H (2002) Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women and the presence of aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human osteoblasts. Mech Ageing Dev 123:1107-1114.
30. Yamaoka K, Tanigawara Y, Nakagawa T, and Uno T (1981) A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 4:879-885.